U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H33NO3.C6H8O7
Molecular Weight 527.6044
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OXELADIN CITRATE

SMILES

OC(=O)CC(O)(CC(O)=O)C(O)=O.CCN(CC)CCOCCOC(=O)C(CC)(CC)C1=CC=CC=C1

InChI

InChIKey=KVKJFNUGVOFNGU-UHFFFAOYSA-N
InChI=1S/C20H33NO3.C6H8O7/c1-5-20(6-2,18-12-10-9-11-13-18)19(22)24-17-16-23-15-14-21(7-3)8-4;7-3(8)1-6(13,5(11)12)2-4(9)10/h9-13H,5-8,14-17H2,1-4H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)

HIDE SMILES / InChI

Molecular Formula C20H33NO3
Molecular Weight 335.4809
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C6H8O7
Molecular Weight 192.1235
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including http://www.fda.gov.ph/consumers-corner/registered-drugs-2/337707-DR-X1387

Oxeladin citrate is a cough suppressant, is a highly potent and effective drug used to treat all types of cough of various etiologies. Withdrawn from the Canadian, US, and UK markets in 1976 due to carcinogenicity. Oxeladine is a component of antitussive drug, Altussan, approved in Philippines.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Altussan

Approved Use

For the relief of all types of cough w/ acute and chronic inflammation due to upper and lower respiratory tract infections
PubMed

PubMed

TitleDatePubMed
Patents

Patents

Sample Use Guides

Cap Adult 1 cap. Syr Adult 1 tbsp (15 mL). Childn 1 tsp (5 mL). Infant ¼-½ tsp (1.25-2.5 mL). All doses to be taken 3 hrly.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:46:31 GMT 2023
Edited
by admin
on Fri Dec 15 17:46:31 GMT 2023
Record UNII
5AEV5C340C
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OXELADIN CITRATE
JAN   MART.   MI   WHO-DD  
Common Name English
Oxeladin citrate [WHO-DD]
Common Name English
2-(2-DIETHYLAMINOETHOXY)ETHYL 2-ETHYL-2-PHENYLBUTYRATE DIHYDROGEN CITRATE
Systematic Name English
OXELADIN CITRATE [MI]
Common Name English
NSC-759231
Code English
OXELADIN CITRATE [MART.]
Common Name English
OXELADIN DIHYDROGEN CITRATE
Common Name English
OXELADIN HYDROGEN CITRATE [EP MONOGRAPH]
Common Name English
OXELADIN CITRATE [JAN]
Common Name English
OXELADIN HYDROGEN CITRATE
EP  
Common Name English
OXELADINE CITRATE
Common Name English
BENZENEACETIC ACID, .ALPHA.,.ALPHA.-DIETHYL-, 2-(2-(DIETHYLAMINO)ETHOXY)ETHYL ESTER, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)
Systematic Name English
Code System Code Type Description
CAS
52432-72-1
Created by admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
PRIMARY
MERCK INDEX
m8299
Created by admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
PRIMARY Merck Index
PUBCHEM
40384
Created by admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
PRIMARY
ECHA (EC/EINECS)
257-910-8
Created by admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
PRIMARY
SMS_ID
100000085506
Created by admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
PRIMARY
EVMPD
SUB03567MIG
Created by admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
PRIMARY
RXCUI
54239
Created by admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
PRIMARY RxNorm
CAS
16485-39-5
Created by admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
SUPERSEDED
ChEMBL
CHEMBL1500276
Created by admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
PRIMARY
FDA UNII
5AEV5C340C
Created by admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
PRIMARY
NSC
759231
Created by admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
PRIMARY
EPA CompTox
DTXSID4046608
Created by admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
PRIMARY
DRUG BANK
DBSALT002252
Created by admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
PRIMARY
MESH
C005461
Created by admin on Fri Dec 15 17:46:31 GMT 2023 , Edited by admin on Fri Dec 15 17:46:31 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY